Published in Women's Health Weekly, October 11th, 2001
"To reduce the number of apheresis procedures and maintain the usual rate of hematopoietic recovery in patients treated with high-dose chemotherapy, we studied the effect of adding a small volume of ex vivo expanded bone marrow to low doses of CD34+ blood stem cells," explained Dr. A.L. Pecora and colleagues at the Hackensack University Medical Center and Progenitor Cell Therapy, L.L.C., in Hackensack, New Jersey; Loyola University in Maywood,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.